Early-stage gastric cancer patients can undergo curative surgery, and then decide whether postoperative adjuvant radiochemotherapy is needed based on the specific pathological type and the presence of high-risk recurrence factors. Through these treatments, a cure can be achieved. Generally, if there is no recurrence or metastasis within five years, it is considered cured. For example, patients in stage IA, even without adjuvant chemotherapy, have a relatively high five-year survival rate, generally above 90% after curative surgery. However, if it is found to be advanced-stage, such as initial detection showing distant metastases to the liver, lungs, etc., these patients are primarily treated with systemic chemotherapy or symptomatic palliative care. In such cases, a cure is not achievable. Therefore, whether a cure is possible depends on the stage of gastric cancer and factors such as the patient's basic physical condition.